OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-03-31-accounts

SECTION 172STATEMENT: STAKEHOLDER ENGAGEMENT SECTION 172STATEMENT: STAKEHOLDER ENGAGEMENT SECTION 172STATEMENT: STAKEHOLDER ENGAGEMENT SECTION 172STATEMENT: STAKEHOLDER ENGAGEMENT SECTION 172STATEMENT: STAKEHOLDER ENGAGEMENT SECTION 172STATEMENT: STAKEHOLDER ENGAGEMENT SECTION 172STATEMENT: STAKEHOLDER ENGAGEMENT
TheTrustee Directors consider that the decisions they have made during the financial
year have satisfied the requirements
of5172(1)ofthe Companies Act 2006and they have
acted ingood faith topromote the success ofthe Institute and, in doing so,have taken
into account the stakeholders
and matters outlined
in5172(1).
TheTrustee Board has the ultimate responsibility
forthe Institute and delivery ofits
charitable objectives.
Thetable below sets out Pirbright's
significant stakeholders.
"
OUR VALUES
Wetake PRIDE in
everything
wedowhich is
reflected in our values:		 '
,		 drIpgk)S4ieij8ejNi.
. .
Ps" L
~r
v
"'j Weengagewithfundersatallstagesofthefundingprocessandhaveregular
„r.lr
.
~ dialogue'and
face to face meetings
with our key investors. Please seepage 20 21
(Jl formore information.
Weengage with the public through our Outreach and Public Engagement
mm-for the highest
qualitystandards,
delivery and		 progra
mmes. These were severely affected in 2021,due tothe COVI0-I 9
pandemic, but events have resumed
in first quarter 2022.Please see page 18for
performance.~—in everything
wedo; leadership,
learning,
biossfety, problem anti cipation		 more information.
Pirbright undertakes
numerous
collaborati
one with
universities,
research
institutes and disease control agencies around the world. More details are given
onpage 28.
and containmentofunexpected Partnerships
with pharmaceutical
companies are essential forthe development		 of
events.~-isthe driving force vaccines, diagnostics and medicines. Find out more onpage 25.
behind our fundamental
and		 Weengage with the farming
community
through
specie listfarming press,
applied science. Our work is through
farming organisations
and bodies and media outlets including 8 BC
positioned atthe cutting-edge World Service and 8BCRadio 4Farming Today as well asatagricultural
events.
ofscience todeliver solutions
forglobal good.
mmmmmI-we		 Employee
En gage
ment
forms acentral part of the institute's strategy Weemploy
avariety ofways tocommunicate
with our staff
and students
in adialogue sowe
respect and tmst in our diverse can also gain feedback. Communication
channels include amonthly e-newsletter,
community. intranet, forums, staffbriefings,
surveys, digital screens, internal seminars, blogs
~-we aim todeliver
the best in all aspects of our
work, including scientific
research, health, safety,
biosafety, stakeholder		 Iet)@I))OEI" sn and workshops. Further information
about our employees canbefound from
page30.
One ofthe ways weengage with our suppliers
isthrough an Annual Supplier Day
held atPirbnght. However due tothe pandemicthis
wasnot possible but digital
*Nhhdr
supportand
protecting the
environment.		 ljI ills , Lh
Vht
lh
d
*h
2
the local community
inanumber ofways including sponsoring
local events,
Wetake PRIDEinbeingaworld-
class centre ofexcellence in		 ,I L volunteering
in local conservation
initiatives including FoxCorner Conservation
and engaging
wrih the Parish, Borough and County Councils over development
scientific research, attracting
experts intheir field from around		 RP on our campus. Our scientists also visit local schools and colleges- more
information
canbefound onpage 18.
the world. This combined
with our drive forprofessional
excellence andriigorous		 AsaMajor Hazard site, Plrbright works closely with the Health &Safety Executive
(H5E),counter terrorism security authorities,
Home Office and other regulators.
Ass National Capabilityfortheprevention
and controlofexoticviral
diseases
academic, biosafetyand
ethical		 oflivestock, Pirbrightworkscloselywith
Defra, BBSRCUKRI and others. Asthe
standards allowsthe
Institute
tohave ameasurable
impact
on health and wellbeing and
economic and food security		 World Reference Laboratory forcertain pathogens
and aregional Reference
Laboratoryfor others, Pirbrightworks
doselywith the UN Food 8IAgriculture
Organisation
(FAO)and World Organisation
forAnimal Health (WOAH). As
an ISO/IEC 17025accredited testing laboratory, Pirbright works with the UK
globally. Accreditation
Service (UKAS).Seepage 15formore details.
Pirbi'ight has avibrant student community,
and we are committed tosupporting,
nurturing
and offering additional
learning and training
opportunities
to them.
Find out more onpage 33.

RISK' CQNNOL lBET(SATO))2
EIOBAI'%(Y. PIDuicd, anginsudog,
opurut(mrd
and mwagement
measures for
, )E)f(@.gi, .(),
EX,
fl)T,
pig)If		 bioluglssl cents(hmsn)
In'camp(Erase wigr relevant UK'lsgIhji((on
(
'
i
a Path
EOgrdsr200S, Cimtmlofguf)
Hamrdotu to4((h~'20022 Qsrts(fcsgy Mo((Ad
organ'umi
(ctohu((nsjd vsp),Rsgulklcyns2014)md
ysexiiM
Appfovsd Cudes'o) PructfseuuA4'guhhv'Me;
lb El(BI(reer'Ifwhh (SO
900('I ISO) tIROI', )BOOS
Iand ISO43001IAlso, soa npal HSE.
Mfjor Hstard Interventiohr Plin, 'and Staffcolmrt ofcompetent Sarlsk
pfsptu'g, apefa(lo)dl aid mafragenventmstuurdr
for s'ecutity'in
confor(BEYwjth Ifcfriretrsnis ofthe UKNauoiial coI(nter Terrorism
Hotuo3NSEQUENeEP
PATH86EN)		 feC'ui'iiy Oghe
.W')j(cove)Ega hy rsglptrul
Co'uiiter'TSI)urbrh
SIyturity
ACh'riaeiur i2af/P'guard
fofcw, bu'drgreund
Straenlng
OfnaW
stavtu(Tk srfd'inukfp elayers ofp)srshil secs)hy.
QUAL(TY Accredltst(op R(the Reference latrarstories to $0/IEC 17025 by
the UKACchh)Wion'Bsrvge
(Pirbrlglit h UKASAccmditsd
Testkrg
'Liguustorygo'402S),
deva(op(turns
sn(fI(np(mnsntagen
ofa
E(uality msfmgtrnhgf
systim ac(usa)he
Instltu(s) sn Intefiial a2ufu
pre'granipw,
End alignment toISO9001andot¹r mlevant
ISO
tmrn'Sgemegt
sth)fdirdg(0
k'sy'openu(onaf
a(usa fur biitter support of
the Reisrenc'e Laboratories.
ANIMALWELPARE Physkml,
opsratiurwl
and managwnent
meauaes for an(mal walfam		 in
compgance with rehvant
UK legislitlbn
(Animal Sdem)fib Piocedures
Act 19B))and assoc(Ried Approved Codes ofPfactice'aru(guidance,
oversr(ghf liy OKNoire 6ffice, a'ppjication of Slys (Rsphice, Refine,
Reduce}and ARRIVE gu(dance (Animal Resesrds Rephrt(ng
In Vrvo
CYBERSEC0R(IY Expw'iments).
Comprehensive
portfolio of'tirchnical
countermeasures
sgd
msnagerrient
sy'st'sms for~Ih'corilonhitywjth
rscpgvprwms
ofthe UKNational Cyber SGCSTSy Omtr'a and HSE
Cugg'6~TIly isehdlremsnis
CrESIIRychgcd c'ontiol systims,
GEIth ahd s'egrugstum
ofafdcui Iesuurcm from networksitralnlng,
dr'Sls4euerclsss, snd allgmniiit
witirC)rbsr E)s'enhh Ptui.
CONTINUI(Y (nadet» snd crlslf nwrsrgegrsnt
piarw
Ibusiness corrt(nuhy
planning
in hsgdment
wkly lscyr 22201,hackr)ps(ind
contlg)(s)Kies foruitical
servic'essed
supplies, and contingency
PIsnsfor ths R+tenor
La
stories'foi disease autbr'asks,
with all pfans Iugdlariy'tested
by
ddjh 8exerdsis.
Recruitmint
0 retention
and rasportslbifrty's~,
traininif'
31
development
progmmrpas,
careerp~ with Itubsnd ment
awards and a'psfsohs( promogon
schein'e, isuipsl!Purformshce
arid
persensl deva(opmwn
reviews s) issoow peru(on piovh(on and life
Eoverr and emp(syau
herrefhs
pls(fhv(n and Mdistsrrceprog)pnme,
Rigorous stutervu forRr(andal planning,
contf9( and rmuiitoring,
o)rguihg fish muuagftnhrtt,
,proces)ss usl fpppoit to.fed(i(ate
pieparatlon,
subfnhiie0 std m'anagemtmt
ofcompegtivhbstding
grants snd csp(tff fgndlfI+gblds,
co(nitwrdafbtu)siss
de'vdlopldaiia
proygsmms
Plihdght'
Inrmvaiions
Ltdssa pdyssg vs)gda for
celhrnsrcfi( tvofk ctunpreherqiva
purtfd(id of kuu'rinse
fm((dss, snii-
fr'aud andEEId~ fujlfdas', anrwallsudl't',
,snd reportage toI(BSRC
furtdw';. fyri~'~Bud sfrataglo partnai
Pat(uniufactumdinobuf(tuwdpfsrmfnfy
hslhdbg
I jlcruufgi(n
Iucurhe'from
Eorhpetitiire' Rfisf(ng score)is snd
approprlatecomhwrc(ej
actlvjdes, md:
vins
from Img
vad
fuocuremwn
snd Bgskc fun(fed 'spend toEEwe' csfftafwo21GL

• p rth*rrpNwJq

klAZARD

44 G c 11 ¢• PP Viral SuFvivalcod@bre3king £a5EatTheFe5tivaloF Tomorrow. Swindon.

Note Unrestricted Itestrlcted 2022 2021
Funds Funds Totalfunds Total Funds
5'000 5'000 8'000 8'000
Income from
Core strategic grant 15,513 15.513 18/928
Charitable activities
Grants and contracts 16,281 24,904 41,185 58,190
Other charitable
income		 1,453 1,452 2,609
Investment
income		 959 959 956
Total Income 18,693 40,417 59,110 80,683
Expenditure
on
Raising funds
Rental propenies
and tenant services		 309 315 624 636
Investment
management		 costs 19 19 18
Charitable
activities
5cientific research 32,701 11,187 43,888 44,850
Rental properties
and tenant services		 1,586 2,025
Other chaditable activities 400 471
Total expenditure 34,413 12,105 46,518 48,000
Net (gains) on Investments 2.000 2,000
Net (expendaure)/income before transfers (15,720) 30,312 14.592 32,683
Transfers between funds 15 15,513 (15,513)
Net movement
in funds		 (207) 14,799 14,592 32,683
Balances brought
forward		 9,997 320,649 330,646 297,683
Balances carried forward 16 9,790 335,448 345,238 330,646
2022 2021
Note 8'000 5'000 5'000
Fixed assets
Tangible fixed assets 9 318,228 295,172
Investment
property		 10 2,000
320,228 295,172
Current assets
Stocks 11 359 264
Debtors 12 10,703 13,397
Term deposits over three months 5,016 23,194
Cash at bank and in hand 29,495 19,237
45,573 56,092
Credkorsr amounts falling due vrhhln one year 13 (20,5631 120.618)
Net current assets 25,010 35,474
Total assets less cermet liabili8es 345,238 330,646
Net assets 345,238 330,646
Financed by
Unrestricted
funds		 16 9.790
Restricted funds
Fixed asset fund 15 330,243 317,191
Investment
revaluation		 reserve 2,000
Other resuicted reserves 3,205 3,458
Total funds 345,238 330,646
Approved
by the Board ofTrustee Directors		 Professor Vince Emery
on 16November 2022and signed on their Trustee Director
behalfon16November 2022.
Rona Chester
The accompanying notes on pages 48to Trustee Director
61forman integralpartofthesefinanoal
000 2022 f'000 2021
f'000 f'000
Ner cash provided byoperating activities
Net movement
in funds		 14,592 32,683
Interest and rent receivable (959) (956)
Depreciation
charged		 9,684 9,469
Increase in valuation ofInvestment Property (2,000)
(Increase)/decrease
in stocks		 (95) 42
Decrease/(increase)
in debtors		 2,694 (6,693)
Increase in creditors 1,255 1,288
Net cash provided
by operating ectlvides		 25,171 35,833
Cash flows from investing activities:
Interest and rents received 959 956
Decrease/(Increase)
in cash		 deposits & 3months 18,178 (2,025)
Purchase of propeny,
plant		 and equipment (34.050) (35,056)
Net cash used in investment activldes (14,913) (36,125)
Change in cash and cash equivalents in the reporting period 10,258 (292)
Cash and cash equivalents at the beginning ofthe reporting 19,237 19,529
period
Cash and cash equivalents at the end ofthe reporting period 29,495 19,237
Cash and cash equivalents asabove 29,495 19,237
finnan
Cash placed on term deposits longer than 3months 5,016 23.194
Cash at bank and In hand 34,511 42,431
Asat Asat
Net cash at Bank 1 Apdl 2021
5'000		 Cashgow
f'000		 31 March 2022
5'000
Cash at Bank 19,237 10,258 29,495
Total 19,237 10,258 29,495
The accompanying
notes on pages		 48to6) form an integral part of these as Istatements

2022 2021
f'000 2'000
BBSRCUKRI —core strategic grant 15,513 'I5,449
Resource concdibution grants 3,479
15,513 18,928

INCOME FROM CHARITABLE ACTIVITIES
2022 2021
f'000 f'000
Grant inmme
BBSRCUKRI —research grants 3,522
BBSRCUKRI-other grants 25,375 43,885
Other research grants 12,288 'I1,345
41,185 58,190
Other charitable activities 1,453 2,609
42,638
2022 2021
f'000 f'000
United Kingdom 37,909 55,636
Europe 569 1,106
North America 2,944 2,573
1,216 1,484
42,638 60,799

INCOME FROM CHARIT A BLE ACTIVITIES (CONTI
Restricted 2022
f'000 Total
f'000
Cunent year
Analysis ofgrant income
BBSRCUKRI
Competitive
Project		 Grant —research grants 3,522 3,522
Other grants 471 24,904 25,375
Total BBSRCUKRI 24,904 28,897
Defra "Umbrella" commission projects 2,395 2,395
Defra Surveillance 3,043 3,043
Other government departments, public sector 665 665
European
Union		 569
Industry.
levy boards		 1,572 1,572
Trusts, foundations, charities 906
Other research grant income 3.138 3,138
Total Income-grants indudlng research 16,281 24,904 41,185
2021
Unrestricted Total
f'000 f'000
Prior year
Analysis ofgrant income
BBSRCUKRI
Competitive
project		 Grant —research grants 2,960 2,960
Other grants 198 43,687
Total BBSRCUKRI 3.15$
Defra "Umbrella" Commission projects 2,250 2,250
Defra Surveillance 2,697 2,697
Other government departments, public sector 540
European
Union		 1,106 1,106
Industry,
levy boards		 1,176 1,176
Trusts, foundations, charities 1,003 1,003
Other research grant income 2,573 2,573
Total Income- grants indudlng resewch 14,503 43,687 5$,190

Other charitable income consists ofna des and activities which are ancillary
to the chadita		 ble activities ofthe institute:
Unresaicted 2022 2021
f'000 Total Total
f'000 2'000
Royalties 373 388
Diagnostic testing 317 317 183
Supply ofreagents 247 247 277
Other 516 516 1,761
1,453 2,&09

2022 2021
5'000 f'000
Rental income and tenant services 930 849
Bank interest 107
959 956

4ANALYSIS OF EXP ENDITURE
Other direct AEocebul 2022
Current year costs
LR000		 support costa
f'000		 Total
f'000
Unrestricted
funds
Costs ofraising funds
Rental income and tenant services
Investment
management		 costs 10 19
Charitable
expenditure
Grants forscientific research 13,131 7,521 12,045 32,697
Rental income and tenant services 988 988
Other charitable activities 212
Total unrestricted
expenditure		 13.131 7,719 13,563 34,413
Restricted funds
Cost ofraising funds 316 316
Charitable expenditure 11,789 11,789
Total restricted expenditure 12,105 12,105
Total expenditure 13.131 7,719 25,6fi8 46,518
Total expenditure
-ZOZI		 13,620 6,251 28,129
Included
in allocated support costs are staffcostsoff4978K(2021:f5034(q
Staffcosts Other Allocated 2021
Prior year f'000 direct costs
f'000		 support casts
f'000		 Total
5'000
Unrestricted
funds
Cosrs ofraising funds
Rental income and tenant services 312 312
Investment
management		 costs 18
Charitable
expenditure
Grants for scientTiic research 13,620 6,043 'I1,976 31,639
Rental income and tenant services (7l 970 963
Other charitable activities 206 216 42Z
Total unrestricted
expenditure		 13,620 6,251 13,483 33,354
Restricted funds
Cost ofraising funds 324
Charitable
expenditure		 14,322 14,322
Total unrestricted
expenditure		 14,646 14,646
Total expenditure 13,620 6,251 28,129 48,000

Rental Rental owens md Scnmc
0 «etta I«md«em mnthach rental hearten
snd tend« wanasmwnt formhntnc wd «anne
mmh ms«sch «evans
2'000 f'000 orna 0000
Cunant year
Unrestricted
Premises 178 7,650 MB 67 8763 nds«as ea
Finanoal costs 25 9 567 44 25 25 695 tlhe snw
Management 32 773 13 15 8 841 tnte spent
Human resources 54 398 16
Information technology 10 2,097 23 12 23 2165
Procurement 473 18 12 6 515 Om sp«»
Governance 87 I 96 Om spent
309 9 12,045 988 149 d3 13,563
Depreciation 8,526 807 50 9,686
Repairs / compliance 13 2,278 128 2,419
316 10,804 935 50 12,105
Total support costs 625 9 22,849 1,923 199 d3 25.668
Immi Sd
h Inwntm ant conhads nmht hm Oewr
andtmnmt mmasemmn Io sde
IN		 andtwmnt Stau deelakl
E'000 f'000 relmerdt
f'000		 «selene
ESRN		 I st w ms st
ETEN		 adishas
f'000		 Tatal 202t
E'000		 Sash al
aamaton
Prior year
Umestrlcted
Premises 174 7,473 867 65 8579 No(Ewraraa
Financia Icosts 27 9 593 46 27 728 tl~spent
Management 39 953 17 19 10 1,038
Human resources 54 391 16 461 time spent
Information technology 10 2,059 23 23 2,126
Purchasing and 16 5 tlm spe t
procurement
Governance 83 1 90 tittle newt
312 9 11,97d 970 151 dg 13,483
Depreoation 8,335 9.469
Repairs / compliance 28 4,876 273 5,177
324 13,211 1,062 49 14,646
9 25,187 ?032 200 65 28.129

2021
5'000
Net (expenditure)/Income isstated after charging.
Auditor's
remuneration
-audit seniices
-noneudit
services (taxation advice)		 21 12
Depreciation 9,684 9,469
Loss on foreign exchange translations 27 189
Hire ofplant and machinery 22 17
Rental oflend and buildings 55 52

Number ofemployees Number ofemployees
2022 2021
Office, managementandestatesupport 121 126
Scientific 247
361 373
he aggregate payroll costs ofthese persons were as follows:
2022 2021
E'000 E'000
Wages and salaries 13,967 14,103
Social security costs 1,432 1,418
Other pension costs 2,549 2,613
17,948 18,134
2022 2021
Termination payments: 8'000 E'000
Redundancy 148 168
168
The numbe r ofstaff with em oluments
grea		 ter than E6
2022 2021
Number Number
13 13
E70,000 —E79,999 6
E80,000 —E89,999 3 4
B6,000 —E99,999 4 4
5110,000 —E119,999
earning		 1 1
5140,000 —5149.999 1 1

of100ordi nary shares ofEieach. shares ofEieach.
The assets and liabilities ofthe subsidiary were:
2022 2021
2'000 2'000
Current assets
Creditors: amounts falling due viithin one year (8) (8)
Net liabilities (8) (8)
Aggregate share capital and reset ves (8) (8)

2022 2021
2'000 2'000
At 1 April 2021
Revaluation in the year
At 31March 2022 2,000

11STOCKS
2022 2021
f'000 f'000
Laboratory
consumables		 359 264
The institute's stockconsists of laboratory supp liesforresearch purposes.
12DEBTORS:AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
f'000 f'000
Trade debtors 1,848 2,181
Prepayments 1,663 1,539
Accrued income 6,996 2.321
Other debtors 196 7,356
10,703 13,397
13CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022
f'000		 2021
f'000
Trade creditors 3,547 2,484
Taxation and social security 156 550
Other creditors 154
Accruals 5,276 7,655
Deferred income 11,094 9,285
Short-term
compensated		 absences 490
20,563 20,618

2022 2021
f'000 f'000
Accrued income 6,996 2,321
Deferred income (11,094) (9,285)
(4098) (6,944)
Net deferred research grant income atthe beginning ofthe year (6,964) (7,440)
Research grant income received duding the year (13,415) (14,027)
Research grant money released to SOFA during the year 16,281 14,503
(4,098} (6,964)

15FUNDS
Balance
Transfer
Balance
1Apr0
Net lncomel
between
31March
Current yean
2021
E'000
expendihne
f'000
funds
f'000
2022
E'000
Unrestricted
funds:
General
Designated
Restricted funds:
Fixed Asset Fund
Other restrinsed
funds:
Fixed Asset Project Support Costs
DP2 phase 2occupation
BBSRCUKRI core grant funding
Brooksby support mats
Investment
property
revaluation
Other
7,504
2,493
317,191
593
1,224
1,573
(15,352j
(368)
13,394
(396)
(199)
15,513
15,263
(250)
(15,513)
7,415
2,375
330,243
539
1.025
1,573
2,000
68
330,646
14,592
345,238
Unrestrkted
designated
funds
Unrestricteddesignatedfundscompiisesums
setasideforspecificpurposesincludmg
the acquisition
andimprovementoftangiblefixed
assets,
the presentation
ofscientific conferences, and conuibutions
towards capital tobe replaced using the fully economic costing policy adopted
for
o her
p ojects
by the Institute
This includes E1,173kforoccupation costs relating tocapital projects (2021:E1,661k),El00ktomaintain scientific equipment
capacity and capability (2021:f41k),f319kforgroup leaders and scientists (2021:f352k)and E783k
(2021;E396k)
Babnce Transfer Balance
1April Net Incomel between 31March
Prior year: 2020
f'000		 expenditme
E'000		 funds
f'000		 2021
f'000
Unrestricted
funds:
General 5,102 (14,953) 17,355 7,504
Designated 3,026 (333) (200) 2,493
Restricted funds:
Fixed Asset Fund 284,798 317,191
Other resn icssd funds:
Fixed Asset Project Support Costs 3,343 (2,750)
DP2 phase 2occupation 1,620 (37) 1,224
154LInterim Insectary 6 (6)
BBSRCUKRImre grant funding 18,928 (18,928)
Brooksby support costs 1,573 1,573
Other 68
297,963 32,683 330,646

Restricted(unde comprise grants received from funda raspecifically comprise grants received from funda raspecifically tobe applied inthe acquisition orimprovement oftangible
fixed assets orotherwise applied for such purposes asspecifiedby the grants provided.
2022 2021
f'000 f'000
Fixed Asset Fund
Balance brought forward 317,191 284,798
Grants received 24,904 43,687
Depreciation/impairment (Note 6) (9,684) (9,469)
Revenue spend (1.826) (4,818)
Transfers (342) 2,993
Balance carried forward 330,243 317,191

Transfers between funds
Unrestricted U wstrkbd
general dedgnased Restricted
funds funds funds
f'000 f'000 f'000
Transfer offunds to general reserves 15,263 250 15,513

Investments Total
f'000 f'000
Cunent year
Un estrkted funds 9,790
Restricted funds
Capital fund 302,945 12,015 314,960
Fixed Asset Revaluation Reswve 15,283 15,283
Investment Property Revaluation Reserve
Other restricted funds 3,205
318,228 25.010 345,238
Net current
Investments Total
EOOO f'000 f'000
Prior year
Unmstrkted funds 9,997
Restricted funds
Capital fund 279,873 22,019 301,892
Revaluation reserve 15,299 15,299
Other restricted funds 3,458
295,172 35,474 330,fi46
17FINANCIAL INSTRUMENTS
2022 2021
EOOO 5'000
Financial assets measured at amortised cost 2,044 9,537
Financial
liabilities measured		 at amortised cost (4,319) (3,188)
6,349

2022 2021
f'000 f'000
6,113 28,835
The capital commitments ofE6,113k(2021:E28 853k)will befunded by the 885RCUKRI capital grants already awarded.
(bjOperating lease commitments
The Institute
iscommittedtothefollowingcharges		 inrespectof:
2022 2021
f'000 f'000
Land and buMlngs
Within one year 52 52
IntwotoFive years 218 210
In over five years 293
Plant and Machinery
Within one year
Intwo tofive years 16